Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D

CompletedOBSERVATIONAL
Enrollment

507

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

September 30, 2021

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

BioMimics 3D Stent

Trial Locations (23)

21075

Asklepios Klinik Harburg, Hamburg

60389

CCB im Agaplesion Bethanien Krankenhaus, Frankfurt am Main

72016

Universitätsklinikum Tübingen, Tübingen

83022

RoMed Klinikum Rosenheim, Rosenheim

98527

SRH-Klinikum Zentralklinikum Suhl, Suhl

Unknown

OLV Hospital, Aalst

ZNA Vascular Clinic/ZNA Stuivenburg Hospital, Antwerp

AZ Sint Blasius, Dendermonde

AZ Maria Middelares, Ghent

Regionaal Vaartcentrum , AZ Helig Hart Tienen, Tienen

Karolinen-Hospital, Arnsberg

Universitaets-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen

KEH Berlin, Berlin

Vivantes Klinikum Friedrichshain, Berlin

Krankenhaus Buchholz, Buchholz

Universitätsklinikum Essen, Essen

UKE (University Hospital Hamburg), Hamburg

Universitätsklinikum Leipzig AöR, Leipzig

Gefäßpraxis im Tal, Munich

Marienhospital Osnabrück GmbH, Osnabrück

Rijnstate Hospital, Arnhem

Skane University Hospital, Malmo

01067

Krankenhaus Dresden-Friedrichstadt, Städtisches Klinikum, Dresden

All Listed Sponsors
lead

Veryan Medical Ltd.

INDUSTRY

NCT02900924 - Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D | Biotech Hunter | Biotech Hunter